$990,000 Differin benzene contamination class action settlement

Galderma Laboratories agreed to a $990,000 class action settlement to resolve claims that it misled consumers about possible benzene contamination in its Differin acne products.

The Differin settlement benefits consumers who purchased Differin Daily Deep Cleanser (5% benzoyl peroxide), Differin Acne Spot Treatment (10% benzoyl peroxide) and/or Differin Maximum Strength Acne Foaming Cleanser (10% benzoyl peroxide) between Jan. 1, 2020, and Feb. 19, 2026.

According to the class action lawsuit, Differin misled consumers by failing to warn them about possible benzene contamination in its acne products. Benzene is a known human carcinogen that can cause leukemia and other blood disorders.

Differin is an acne treatment brand owned by Galderma Laboratories. The brand’s products, including Differin Acne Spot Treatment, are available at retailers such as Walmart, Walgreens and CVS.

Differin has not admitted any wrongdoing but agreed to a $990,000 class action settlement to resolve the allegations.

Under the terms of the Differin settlement, class members can receive a cash payment for the purchase of eligible products. With proof of purchase, class members can claim an unlimited number of products for a payment of $9 per product.

Without proof of purchase, class members can claim up to three products for a payment of $9 per product. Class members who claim three products without proof of purchase will receive a total of $27.

The deadline for exclusion and objection to the class action settlement is May 19, 2026.

The final approval hearing for the Differin settlement is scheduled for June 30, 2026.

To receive settlement benefits, class members must submit a valid claim form by May 19, 2026.

Who’s Eligible

The class action settlement benefits consumers who purchased Differin Daily Deep Cleanser (5% benzoyl peroxide), Differin Acne Spot Treatment (10% benzoyl peroxide) and Differin Maximum Strength Acne Foaming Cleanser (10% benzoyl peroxide) products between Jan. 1, 2020, and Feb. 19, 2026.

Potential Award

From $9 to $27 without proof of payment, or unlimited claims with proof of payment.

Proof of Purchase

Proof of payment can include physical receipts, online payment records or similar documentation. Proof of purchase is not required for up to three product purchases.

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

05/19/2026

Case Name

Williams v. Galderma Laboratories LP, Case No. 1:24-cv-02222, in the U.S. District Court for the Northern District of Illinois

Final Hearing

06/30/2026

Settlement Website

DifferinBPOProductSettlement.com

Claims Administrator

Differin BPO Product Claims Administrator
P.O. Box 4100
Portland, OR 97208-4100
[email protected]
877-317-7638

Class Counsel

R. Jason Richards
AYLSTOCK, WITKIN, KREIS & OVERHOLTZ PLLC

Matthew A. Girardi
BURSON & FISHER P.A.

Gary M. Klinger
MILBERG PLLC

Trenton Ross Kashima
BRYSON HARRIS SUCIU & DEMAY PLLC

Defense Counsel

Paige H. Sharpe
Anand Agneshwar
Daniel Raymond
ARNOLD & PORTER KAYE SCHOLER LLP